Alpha Tau Medical (DRTS) News Today → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free DRTS Stock Alerts $2.83 +0.16 (+5.99%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 5:44 AM | americanbankingnews.comHC Wainwright Reiterates "Buy" Rating for Alpha Tau Medical (NASDAQ:DRTS)May 16, 2024 | marketbeat.comAlpha Tau Medical (NASDAQ:DRTS) Earns "Buy" Rating from HC WainwrightHC Wainwright reissued a "buy" rating and issued a $9.00 price target on shares of Alpha Tau Medical in a research note on Thursday.May 13, 2024 | globenewswire.comAlpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal CancerMay 6, 2024 | globenewswire.comAlpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in GlasgowMay 1, 2024 | globenewswire.comAlpha Tau to Participate in May Investor ConferencesMarch 31, 2024 | marketbeat.comAlpha Tau Medical Ltd. (NASDAQ:DRTS) Sees Large Increase in Short InterestAlpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) was the recipient of a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 34,900 shares, a growth of 22.5% from the February 29th total of 28,500 shares. Approximately 0.1% of the company's stock are short sold. Based on an average daily volume of 34,500 shares, the days-to-cover ratio is currently 1.0 days.March 25, 2024 | globenewswire.comAlpha Tau to Present at the Jefferies Radiopharma Innovation SummitMarch 15, 2024 | marketbeat.comAlpha Tau Medical Ltd. Expected to Earn FY2024 Earnings of ($0.49) Per Share (NASDAQ:DRTS)Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) - Equities researchers at HC Wainwright lifted their FY2024 earnings per share estimates for shares of Alpha Tau Medical in a research report issued on Tuesday, March 12th. HC Wainwright analyst Y. Chen now expects that the company will post earnMarch 12, 2024 | markets.businessinsider.comBuy Rating Affirmed: Anticipating Alpha Tau Medical’s Clinical Milestones and Growth Potential in 2024March 7, 2024 | globenewswire.comAlpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate UpdateFebruary 26, 2024 | globenewswire.comAlpha Tau to Participate in Barclays 26th Annual Global Healthcare ConferenceJanuary 8, 2024 | benzinga.comAlpha Tau Medical Stock (NASDAQ:DRTS), Quotes and News SummaryDecember 20, 2023 | finance.yahoo.comAlpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceDecember 16, 2023 | marketbeat.comAlpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Up 12.9% in NovemberAlpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) was the target of a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 73,500 shares, a growth of 12.9% from the November 15th total of 65,100 shares. Approximately 0.2% of the shares of the stock are sold short. Based on an average trading volume of 25,700 shares, the days-to-cover ratio is presently 2.9 days.December 15, 2023 | marketbeat.comAlpha Tau Medical (NASDAQ:DRTS) Now Covered by Analysts at CitigroupCitigroup assumed coverage on shares of Alpha Tau Medical in a report on Friday. They issued a "buy" rating and a $8.00 target price on the stock.November 28, 2023 | finance.yahoo.comAlpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic CancerNovember 20, 2023 | finance.yahoo.comAlpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck CancerNovember 17, 2023 | markets.businessinsider.comAnalyst Ratings for Alpha Tau MedicalNovember 16, 2023 | msn.comAlpha Tau Medical GAAP EPS of $0.31October 30, 2023 | finance.yahoo.comAlpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing FacilitySeptember 16, 2023 | finance.yahoo.comHere's Why We're Not Too Worried About Alpha Tau Medical's (NASDAQ:DRTS) Cash Burn SituationSeptember 14, 2023 | stockhouse.comAlpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel's Hadassah Medical CenterSeptember 1, 2023 | marketbeat.comCantor Fitzgerald Weighs in on Alpha Tau Medical Ltd.'s FY2023 Earnings (NASDAQ:DRTS)Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) - Equities researchers at Cantor Fitzgerald upped their FY2023 earnings estimates for Alpha Tau Medical in a note issued to investors on Tuesday, August 29th. Cantor Fitzgerald analyst K. Kluska now anticipates that the company will post earningsAugust 24, 2023 | finance.yahoo.comAlpha Tau Medical to Participate in September Investor ConferencesAugust 18, 2023 | marketbeat.comAlpha Tau Medical (NASDAQ:DRTS) Receives Buy Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $9.00 price target on shares of Alpha Tau Medical in a report on Friday.August 17, 2023 | finance.yahoo.comAlpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRTAugust 8, 2023 | marketbeat.com35,070 Shares in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Purchased by ProVise Management Group LLCProVise Management Group LLC purchased a new stake in Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 35,070 shares of the company's stock, valued at approximaAugust 2, 2023 | finance.yahoo.comAlpha Tau Medical to Present at the Emerging Growth Conference on August 9th, 2023July 2, 2023 | marketbeat.comETF Managers Group LLC Takes $190,000 Position in Alpha Tau Medical Ltd. (NASDAQ:DRTS)ETF Managers Group LLC bought a new stake in Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 66,326 shares of the company's stock, valued at approximately $May 29, 2023 | marketbeat.comEquities Analysts Set Expectations for Alpha Tau Medical Ltd.'s Q2 2023 Earnings (NASDAQ:DRTS)Alpha Tau Medical Ltd. (NASDAQ:DRTS - Get Rating) - Analysts at HC Wainwright reduced their Q2 2023 earnings per share estimates for Alpha Tau Medical in a report released on Wednesday, May 24th. HC Wainwright analyst Y. Chen now expects that the company will earn ($0.12) per share for the quarteMay 25, 2023 | markets.businessinsider.comH.C. Wainwright Keeps Their Buy Rating on Alpha Tau Medical Ltd (DRTS)May 24, 2023 | finance.yahoo.comAlpha Tau Medical to Participate in June Investor ConferencesMay 23, 2023 | msn.comRecap: Alpha Tau Medical Q1 EarningsMay 22, 2023 | finance.yahoo.comShould You Buy Alpha Tau Medical (DRTS) Ahead of Earnings?May 18, 2023 | markets.businessinsider.comAlpha Tau Medical Ltd (DRTS) Receives a Buy from H.C. WainwrightMay 17, 2023 | finance.yahoo.comAlpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer in Novel Clinical Trial with Cambridge UniversityMay 11, 2023 | finance.yahoo.comAlpha Tau Announces the Publication of its US Multicenter Pilot Skin Cancer Trial Results in JAMA Network OpenMay 3, 2023 | finance.yahoo.comAlpha Tau Medical to Present at Guggenheim Radiopharmaceuticals DayApril 24, 2023 | msn.comAlpha Tau Medical a new buy at HC Wainwright on proprietary radiation therapyMarch 8, 2023 | finance.yahoo.comAlpha Tau Announces Alpha DaRT™ Treatment of First Two Patients in its Pivotal Multicenter Recurrent Skin Cancer (ReSTART) TrialMarch 1, 2023 | finance.yahoo.comAlpha Tau Announces Health Canada Authorization for Alpha DaRT Clinical Trial for the Treatment of Liver MetastasesDecember 19, 2022 | marketbeat.comShort Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Drops By 15.6%Alpha Tau Medical Ltd. (NASDAQ:DRTS - Get Rating) saw a large decrease in short interest during the month of November. As of November 30th, there was short interest totalling 138,400 shares, a decrease of 15.6% from the November 15th total of 163,900 shares. Currently, 0.4% of the shares of the stock are short sold. Based on an average trading volume of 51,200 shares, the days-to-cover ratio is currently 2.7 days.December 13, 2022 | finance.yahoo.comAlpha Tau to Present at Biotech Showcase and Participate in LifeSci Advisors Corporate Access Event During J.P. Morgan Healthcare Conference in San Francisco in January 2023November 23, 2022 | marketbeat.comAlpha Tau Medical (NASDAQ:DRTS) PT Lowered to $12.00Piper Sandler dropped their target price on Alpha Tau Medical from $19.00 to $12.00 in a report on Wednesday.November 23, 2022 | finanznachrichten.deAlpha Tau Medical Ltd.: Alpha Tau Medical Announces Third Quarter 2022 Financial Results and Provides Corporate UpdateNovember 9, 2022 | finance.yahoo.comAlpha Tau to Present at Upcoming November Investor ConferencesOctober 21, 2022 | finance.yahoo.comAlpha Tau Announces Multiple Corporate Updates Ahead of 2022 Annual Meeting of the American Society for Radiation OncologyOctober 4, 2022 | marketbeat.comAlpha Tau Medical Ltd. (NASDAQ:DRTS) Sees Significant Growth in Short InterestAlpha Tau Medical Ltd. (NASDAQ:DRTS - Get Rating) saw a significant growth in short interest in the month of September. As of September 15th, there was short interest totalling 237,800 shares, a growth of 7.6% from the August 31st total of 221,000 shares. Based on an average daily volume of 57,900 shares, the days-to-cover ratio is currently 4.1 days. Approximately 0.7% of the company's shares are short sold.September 24, 2022 | seekingalpha.comDRTS Alpha Tau Medical Ltd.September 19, 2022 | finance.yahoo.comAlpha Tau Medical Ltd.'s (NASDAQ:DRTS) largest shareholders are individual investors with 47% ownership, insiders own 26% Get Alpha Tau Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter. Email Address Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble. Click here if you’d like to learn more about these five cryptos… DRTS Media Mentions By Week DRTS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DRTS News Sentiment▼0.150.42▲Average Medical News Sentiment DRTS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DRTS Articles This Week▼40▲DRTS Articles Average Week Get Alpha Tau Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: OBIO News QIPT News DCTH News CVRX News PROF News CLPT News ARAY News TELA News RCEL News NPCE News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DRTS) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarShocking: One AI startup's revenue could surge 4,735%Manward PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Tau Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
